gvtcx

Neuromodulation Devices Consumables and Associated Products 2023

NHS Supply Chain Published 24 Nov 2023 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£392,000,000
Statuscomplete
Category (CPV) 33158210
Deadline15 Jun 2023
Procedureopen
OCIDocds-h6vhtk-03a7ab

Awards (23)

This procurement was awarded to 23 suppliers. Values shown are per-award; the notice total is £392,000,000.

SupplierValueDateStatus
Abbott Medical U.K.Ltd shared · · active
Avanos Medical UK Limited shared · · active
Axonics Modulation Technologies UK Limited shared · · active
Boston Scientific Ltd shared · · active
BVM MEDICAL LTD shared · · active
Charco Neurotech Ltd shared · · active
electroCore UK Ltd. shared · · active
Far From Surgical Solutions shared · · active
Flow Neuroscience shared · · active
Freedom Neuro BV shared · · active
Inomed Neurocare Limited shared · · active
Inspire Medical Systems shared · · active
LivaNova UK Limited shared · · active
Mainstay Medical Distribution Ltd shared · · active
Medtronic Limited shared · · active
Nevro Medical Limited shared · · active
Nyxoah SA shared · · active
Optimus Medical Ltd shared · · active
P14 Medical Limited shared · · active
PHAGENESIS LTD shared · · active
Polar Medical Ltd shared · · active
Precisis GmbH shared · · active
Saluda Medical shared · · active

description

"Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures.

Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00"

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
6 Apr 2022 Planning (planning) · e3228460-b61d-4ec9-8ea2-9402e0937044-525567
23 Feb 2023 Prior information notice (F01) Earlier regulations 005377-2023
18 May 2023 Contract notice (F02) Earlier regulations 014196-2023
24 Nov 2023 Contract award notice (F03) Earlier regulations 034841-2023

more from NHS Supply Chain

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.